15.—(1) These Regulations do not apply to an inactivated autogenous vaccine that is manufactured, on the instructions of a veterinary surgeon, from pathogens or antigens obtained from an animal and used for the treatment of that animal.
(2) Schedule 1 and Part 1 of Schedule 2 do not apply in relation to an inactivated autogenous vaccine that is—
(a)manufactured by a person and in premises authorised in accordance with Part 2 of Schedule 2, on the instructions of a veterinary surgeon, from pathogens or antigens obtained from an animal; and
(b)used for the treatment of—
(i)other animals on the same site;
(ii)animals intended to be sent to those premises; or
(iii)animals on a site that receives animals from those premises.
(3) Schedule 1 and Part 1 of Schedule 2 do not apply in relation to—
(a)blood or blood constituents from a blood bank authorised in accordance with [F1Part 2] of Schedule 2;
(b)a product manufactured for administration under the cascade by a person and in premises authorised in accordance with [F2Part 2] of Schedule 2; or
(c)F3... stem cell products for use as an autologous treatment for [F4non-food producing animals] from an F3... collection centre authorised in accordance with [F5Part 2] of Schedule 2.
(4) Schedule 6 (exemptions for small pet animals) has effect.
Extent Information
E1This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only
Textual Amendments
F1Words in reg. 15(3)(a) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 10(a)
F2Words in reg. 15(3)(b) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 10(b)
F3Word in reg. 15(3)(c) omitted (E.W.S.) (17.5.2024) by virtue of The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 10(c)(i)
F4Words in reg. 15(3)(c) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 10(c)(ii)
F5Words in reg. 15(3)(c) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 10(c)(iii)
15.—(1) These Regulations do not apply to an inactivated autogenous vaccine that is manufactured, on the instructions of a veterinary surgeon, from pathogens or antigens obtained from an animal and used for the treatment of that animal.
(2) Schedule 1 and Part 1 of Schedule 2 do not apply in relation to an inactivated autogenous vaccine that is—
(a)manufactured by a person and in premises authorised in accordance with Part 2 of Schedule 2, on the instructions of a veterinary surgeon, from pathogens or antigens obtained from an animal; and
(b)used for the treatment of—
(i)other animals on the same site;
(ii)animals intended to be sent to those premises; or
(iii)animals on a site that receives animals from those premises.
(3) Schedule 1 and Part 1 of Schedule 2 do not apply in relation to—
(a)blood or blood constituents from a blood bank authorised in accordance with Part 3 of Schedule 2;
(b)a product manufactured for administration under the cascade by a person and in premises authorised in accordance with Part 4 of Schedule 2; or
(c)equine stem cell products for use as an autologous treatment for horses from an equine collection centre authorised in accordance with Part 5 of Schedule 2.
(4) Schedule 6 (exemptions for small pet animals) has effect.
Extent Information
E2This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only